Skip to main content

Cerevel Therapeutics Holdings, Inc.

CEREDelisted Aug 1, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001805387

Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2022 vs. Q1 2022

How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CERE: Q1 2022 compared with Q2 2022
MeasureQ1 2022Of which not filed for Q2 2022Q2 2022Change
Holders1073109+5
Shares122.1M39.5K124.1M+2.09M (+1.7%)
Value$4.27B$1.38M$3.28B−$989.1M (−23.2%)

3 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (19)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CERE in Q2 2022
InstitutionSharesValue% of portfolio
Hood River Capital Management LLC423,250$11.2M0.44%
Point72 Asset Management, L.P.202,300$5.35M0.03%
Bank of Montreal131,970$3.70M0.00%
Caption Management, LLC36,400$962.0K0.09%
HighVista Strategies LLC28,450$752.0K0.45%
SG Americas Securities, LLC19,671$520.0K0.01%
Mirae Asset Global Investments Co., Ltd.15,677$414.0K0.00%
Public Employees Retirement Association of Colorado13,713$363.0K0.00%
State Board of Administration of Florida Retirement System13,710$362.0K0.00%
Simplex Trading, LLC12,491$330.0K0.01%
Man Group plc–$321.0K0.00%
SEI Investments Co11,131$294.0K0.00%
SG3 Management, LLC10,000$264.0K0.50%
E Fund Management Co., Ltd.8,484$224.0K0.02%
Amundi7,055$190.0K0.00%
Cutler Group LP4,253$112.0K0.02%
Group One Trading, L.P.3,063$81.0K0.00%
Itau Unibanco Holding S.A.121$3.00K0.00%
Dark Forest Capital Management LP2$00.00%

Sold out (14)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CERE in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Alyeska Investment Group, L.P.105,000$3.68M
Verition Fund Management LLC82,135$2.88M
Affinity Asset Advisors, LLC70,000$2.45M
Millennium Management LLC45,371$1.59M
Jane Street Group, LLC23,434$820.0K
Blueshift Asset Management, LLC10,268$359.0K
Renaissance Technologies LLC9,900$347.0K
Squarepoint Ops LLC9,403$329.0K
Atom Investors LP8,835$309.0K
ProShare Advisors LLC7,642$268.0K
Centaurus Financial, Inc.3,000$105.0K
TCI Wealth Advisors, Inc.149$5.00K
Fortitude Advisory Group L.L.C.57$2.00K
TCWP LLC22$0

Not filed for Q2 2022 yet (3)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CERE in Q1 2022 that haven't filed for Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Parametric Portfolio Associates LLC23,090$808.0K
Virginia Retirement Systems Et Al9,800$343.0K
Amalgamated Financial Corp.6,633$232.0K